Log In
BCIQ
Print this Print this
 

Elestrin, estradiol (formerly Bio-E-Gel)

  Manage Alerts
Collapse Summary General Information
Company Antares Pharma Inc.
DescriptionBioidentical estradiol transdermal gel
Molecular Target Estrogen receptor 1 (ESR1)
Mechanism of ActionHormone replacement therapy
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMenopause
Indication DetailsTreat moderate to severe hot flashes caused by menopause
Regulatory Designation
PartnerANI Pharmaceuticals Inc.;
Endo International plc;
Meda AB;
Mission Pharmacal Co.;
Valeant Pharmaceuticals International Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$95.0M

$95.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/22/2012

$95.0M

$95.0M

0

Get a free BioCentury trial today